Implementing Sensor-Based CGM in the Managed Care Setting
A Managed Care-Focused Roadmap For Authorizing, Coding, Patient Selection, and Deploying CGM Across the Spectrum of Diabetes Care


Program Medium 
Internet-based program

Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CE/CME credit for this activity. During the period November 18, 2022 through November 18, 2024, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view the activity, totaling 1.5 hours, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CE/CME certificate.

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.

If you have questions regarding the certification of this activity, please contact PIM via email at

Estimated Time to Complete Educational Activity
1.5 hours. Participants must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CE/CME credit.

Course Overview
In this web-based program, physicians will learn how recent developments in flash glucose monitoring have advanced the management of Type 2 and Type 1 diabetes.

Release Date
November 18, 2022

Expiration Date
November 18, 2024


Educational Objectives
Upon completion of this activity, participants will be able to:

  • Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best implement CGM-based technologies into their overall diabetes care plans for persons with diabetes within the managed care environment
  • Detail the practical implementation perspective of sensor-based continuous glucose monitoring in the managed care setting to optimize clinical outcomes, target goal attainment, and comprehensive health metrics in persons across the diabetes spectrum, especially persons with Type 2 diabetes
  • Identify appropriate persons with diabetes who can benefit from the use of sensor-based glucose monitoring to optimize glycemic and health metrics, including persons on basal insulin therapy as well as those only on oral antidiabetics drugs.
  • Discuss the rationale and evidence for pharmacists and physicians recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies in the managed care setting
  • Navigate the processes, challenges, and requirements required to achieve authorization for the use of sensor-based CGM in the managed care setting

Intended Audience
This complimentary CE/CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with type 2 or type 1 diabetes, including pharmacists, endocrinologists, diabetes specialists, family medicine specialists, primary care physicians, physician associates, and related clinicians.

Participation in this activity is complimentary, and clinicians are invited to view this CE/CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support
This activity is supported by an independent medical education grant from Abbott Diabetes Care.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMEducation Resources.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-22-480-H01-P

Type of Activity: Knowledge

Program Faculty and Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Endocrinology and Metabolist Institute
Cleveland, OH

Speaker’s Bureau/Non-CME Speaking: Abbott, Dexcom, Medtronic, Insulet, Novo Nordisk, Bayer
Consultat/Advisory Board: Sanofi, Lilly, Tempramed, Undermyfork

Eden Miller, DO  
Diabetes and Obesity Care LLC
St. Charles Hospital  
Bend, OR

Grant/Research Support: Abbott
Speakers Bureau/Non-CME Speaking: Abbott, Novo Nordisk, Eli Lilly, Bayer, Boehringer-Ingelheim
Consultant/Advisory Board: Bayer, Abbott, Sanofi, Mankind, Eli Lilly, Boehringer-Ingelheim

Irl Hirsch, MD
Professor of Medicine
Diabetes Treatment and Teaching Chair
University of Washington Medical Center
Medical Director
UWMC Diabetes Care Center
Seattle Washington

Grant/Research Support: Dexom and Insulet—all funds to the University of Washington
Consultant/Advisory Board: Abbott, Hagar, Lifescan

Planners, Program Managers and Web Editor Disclosure 
PIM and CMEducation Resources Planners, program managers and web editors have nothing to disclose

Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

  • We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
  • For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
  • We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
  • If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
  • You should check this privacy policy periodically to see whether we have made any changes.

Copyright © 2022 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity. Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.